Giiant Pharma adds to seed funding, AQC, CQDM invest

Montreal-based Giiant Pharma, developer of a precision delivery technology platform in gastroenterology, has raised an additional C$1.25 million for its seed financing.

ByIris Dorbian

30 June 2021•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Canada North America Healthcare Briefs

Giiant Pharma adds to seed funding, AQC, CQDM invest

AQC Capital

Amplitude Ventures

Genesys Capital

Related articles